Non-small Cell Lung Cancer (NSCLC), Stage IV

Also known as: Non-small-cell Lung Cancer (NSCLC) Stage IV / Stage 4 Non-small cell lung cancer / Lung Cancer Non-small Cell Stage IV / Non-small Cell Lung Cancer (NSCLC) Stage IV / Non-small cell lung cancer stage IV / Non-small cell lung cancer metastatic

DrugDrug NameDrug Description
DB00441GemcitabineA nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer.
DrugDrug NamePhaseStatusCount
DB05928Dovitinib1Terminated1
DB00530Erlotinib1Terminated1
DB00135Tyrosine1Terminated1
DB09330Osimertinib2Recruiting1
DB00958Carboplatin3Recruiting2
DB06643Denosumab3Active Not Recruiting1
DB12349Dulanermin3Active Not Recruiting1
DB01229Paclitaxel3Recruiting1
DB00642Pemetrexed3Recruiting1
DB00945Acetylsalicylic acidNot AvailableNot Yet Recruiting1
DB09330OsimertinibNot AvailableNot Yet Recruiting1